ClinicalTrialsFinder

CML, Refractory Clinical Trials in Uijeongbu-si, Gyeonggi-do

1 recruitingUijeongbu-si, Gyeonggi-do, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

Chronic Myeloid Leukemia, Chronic PhaseCML, Chronic PhaseCML, Refractory+1 more
Il-Yang Pharm. Co., Ltd.173 enrolled18 locationsNCT03459534